Microfluidics, Bioengineering, Biotechnology, Pharmaceutical, Innovation.
conditions or fluid forces sufficient to temporarily porate the cell membrane — this allows for constructs like Cas9 ribonucleoproteins (Cas9-RNPs) to enter the cell cytoplasm. Our current µVS prototypes can quickly process tens of million of cells while preserving native cell states1. This is